Key result
Mildronate offers cardioprotective benefits as an adjunctive therapy for patients with stable angina and those in the rehabilitation period following a myocardial infarction.
Why the study?
Does mildronate improve outcomes in patients with stable angina or in the rehabilitation period after myocardial infarction?
Does mildronate improve outcomes in patients with stable angina or in the rehabilitation period after myocardial infarction?
This review summarizes the current evidence and practical aspects of using the cardioprotector mildronate in patients with stable angina or recovering from myocardial infarction.
The review discusses the benefits and various practical aspects of the new cardioprotector mildronate use in cardiology. The latest evidence on the mildronate role in complex therapy of patients with stable angina, or patients in the rehabilitation period after myocardial infarction, is summarised.
No takes yet. Share an insight, caveat, or question.
Михин et al. (2012) studied this question. Mildronate offers cardioprotective benefits as an adjunctive therapy for patients with stable angina and those in the rehabilitation period following a myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: